<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/global/feed/rss.xslt" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podaccess="https://access.acast.com/schema/1.0/" xmlns:acast="https://schema.acast.com/1.0/">
    <channel>
		<ttl>60</ttl>
		<generator>acast.com</generator>
		<title>The B2B Podcast</title>
		<link>https://feeds.acast.com/public/shows/the-b2b-podcast</link>
		<atom:link href="https://feeds.acast.com/public/shows/686e5d928d3d6839f4faaadc" rel="self" type="application/rss+xml"/>
		<language>en</language>
		<copyright>GlobalData Marketing Solutions</copyright>
		<itunes:keywords/>
		<itunes:author>GlobalData Marketing Solutions</itunes:author>
		<itunes:subtitle/>
		<itunes:summary><![CDATA[<p>GlobalData is a leading data analytics and research company providing market intelligence and business intelligence in the world’s largest industries. Our marketing solutions division harnesses this data through our network of 40+ B2B news websites in industries such as, Technology, Financial Services, Healthcare &amp; Life Sciences, Mining, FDI and Energy.&nbsp;</p><br><p>Through our podcast we partner with the worlds most forward thinking and innovative companies to discuss topics affecting the biggest industries globally.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		<description><![CDATA[<p>GlobalData is a leading data analytics and research company providing market intelligence and business intelligence in the world’s largest industries. Our marketing solutions division harnesses this data through our network of 40+ B2B news websites in industries such as, Technology, Financial Services, Healthcare &amp; Life Sciences, Mining, FDI and Energy.&nbsp;</p><br><p>Through our podcast we partner with the worlds most forward thinking and innovative companies to discuss topics affecting the biggest industries globally.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
		<itunes:explicit>false</itunes:explicit>
		<itunes:owner>
			<itunes:name>GlobalData Marketing Solutions</itunes:name>
			<itunes:email>info+686e5d928d3d6839f4faaadc@mg-eu.acast.com</itunes:email>
		</itunes:owner>
		<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
		<acast:showUrl>the-b2b-podcast</acast:showUrl>
		<acast:signature key="EXAMPLE" algorithm="aes-256-cbc"><![CDATA[wbG1Z7+6h9QOi+CR1Dv0uQ==]]></acast:signature>
		<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmTHg2/BXqPr07kkpFZ5JfhvEZqggcpunI6E1w81XpUaBscFc3skEQ0jWG4GCmQYJ66w6pH6P/aGd3DnpJN6h/CD4icd8kZVl4HZn12KicA2k]]></acast:settings>
        <acast:network id="65c4a51d94623a00166c3a1a" slug="rob-manning-65c4a51d94623a00166c3a1a"><![CDATA[Rob Manning]]></acast:network>
		<itunes:type>episodic</itunes:type>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1763634251967-9a0db0ab-d565-42f1-a04f-e12d9e8c7f95.jpeg"/>
			<image>
				<url>https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1763634251967-9a0db0ab-d565-42f1-a04f-e12d9e8c7f95.jpeg</url>
				<link>https://feeds.acast.com/public/shows/the-b2b-podcast</link>
				<title>The B2B Podcast</title>
			</image>
		<item>
			<title>The Future of Tech – Key Themes for 2026 and Beyond</title>
			<itunes:title>The Future of Tech – Key Themes for 2026 and Beyond</itunes:title>
			<pubDate>Wed, 01 Apr 2026 10:18:31 GMT</pubDate>
			<itunes:duration>21:11</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/69ccf0fa4c2da3ddc303032c/media.mp3" length="35600781" type="audio/mpeg"/>
			<guid isPermaLink="false">69ccf0fa4c2da3ddc303032c</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/69ccf0fa4c2da3ddc303032c</link>
			<acast:episodeId>69ccf0fa4c2da3ddc303032c</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOYmdLAioHHfovv5VMxuQdy9YMLG/r9CIJURShS807R1GhDL28WV+hRUsSRbDfhcFhWSWltsKPiCQDrF6H4Ucsa]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1775038258485-1e936e92-1216-42d1-83c1-734863b5f313.jpeg"/>
			<description><![CDATA[<p>This podcast explores the technology shifts set to reshape value creation, capital allocation and dealmaking from 2025 to 2035. Produced in association with Sterling Technology, the podcast is aimed at investors, M&amp;A dealmakers and corporate strategists. The episode will also highlight the most important themes driving changes in the world of technology, and the opportunities that come with them. </p><br><p>The guest is Isabel Al-Dhahir, Principal Analyst in the Strategic Intelligence division at GlobalData.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This podcast explores the technology shifts set to reshape value creation, capital allocation and dealmaking from 2025 to 2035. Produced in association with Sterling Technology, the podcast is aimed at investors, M&amp;A dealmakers and corporate strategists. The episode will also highlight the most important themes driving changes in the world of technology, and the opportunities that come with them. </p><br><p>The guest is Isabel Al-Dhahir, Principal Analyst in the Strategic Intelligence division at GlobalData.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Driving Linked Data Insights: The Complexities and Experiences</title>
			<itunes:title>Driving Linked Data Insights: The Complexities and Experiences</itunes:title>
			<pubDate>Tue, 03 Feb 2026 10:42:21 GMT</pubDate>
			<itunes:duration>24:41</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/6981d10fc8310ac486dc0ce5/media.mp3" length="41470602" type="audio/mpeg"/>
			<guid isPermaLink="false">6981d10fc8310ac486dc0ce5</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/6981d10fc8310ac486dc0ce5</link>
			<acast:episodeId>6981d10fc8310ac486dc0ce5</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeP0ieNAhm3Tz6gKicaRXHqasomaO2Ss9HwyBtZprATBtat/ri4e6s7qGpIM8F7ygdEVNVEU4kCnw9CR2eVKIpOK]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1770301962414-389c6e4b-1d07-45c1-b945-f74e05e27836.jpeg"/>
			<description><![CDATA[<p>This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by MarketScan®.</p><br><p>Episode five explores the evolving landscape of real-world data, brought to you by MarketScan, a Truven Data Solution.</p><br><p>You will hear an open discussion on the complexities and experiences with driving meaningful insights from linked data.&nbsp;</p><br><p>The guests from MarketScan are:</p><p> </p><p>- Liisa Palmer, Portfolio Leader for Real-World Data Research &amp; Analytics</p><p>- And Rachel Connolly, Senior Director of Alliance Partnerships</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by MarketScan®.</p><br><p>Episode five explores the evolving landscape of real-world data, brought to you by MarketScan, a Truven Data Solution.</p><br><p>You will hear an open discussion on the complexities and experiences with driving meaningful insights from linked data.&nbsp;</p><br><p>The guests from MarketScan are:</p><p> </p><p>- Liisa Palmer, Portfolio Leader for Real-World Data Research &amp; Analytics</p><p>- And Rachel Connolly, Senior Director of Alliance Partnerships</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>The Future of Industrials – Key Themes for 2025 and Beyond</title>
			<itunes:title>The Future of Industrials – Key Themes for 2025 and Beyond</itunes:title>
			<pubDate>Tue, 02 Dec 2025 17:08:12 GMT</pubDate>
			<itunes:duration>28:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/692f1cfd042629ee0e23b79b/media.mp3" length="40475543" type="audio/mpeg"/>
			<guid isPermaLink="false">692f1cfd042629ee0e23b79b</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/692f1cfd042629ee0e23b79b</link>
			<acast:episodeId>692f1cfd042629ee0e23b79b</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeO/hyvZVzdDCgWIIFLSfLmJI9nLEyC9zpo7erRXzYroZPKwPdu0hCUSniaCDYrKzfhOG+maqjfQ2JrMJ+4rTOrJ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1765794552352-7cfaeb51-4254-4b95-8019-b101da4e97c0.jpeg"/>
			<description><![CDATA[Designed for industrials M&amp;A dealmakers and investors, this podcast highlights the most important themes driving major changes reshaping heavy industry across the globe. The conversation covers the key themes dominating industrials: smart industry technologies, structural shifts like Industry 4.0, ESG, M&amp;A intelligence and the macro risk to be aware of. This podcast is sponsored by Sterling Technology - the provider of premium virtual data room solutions for secure sharing of content and collaboration for industrials dealmaking. Hosted by Tom Lawrence and featuring David Bicknell, principal analyst at GlobalData covering the industrials sector.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[Designed for industrials M&amp;A dealmakers and investors, this podcast highlights the most important themes driving major changes reshaping heavy industry across the globe. The conversation covers the key themes dominating industrials: smart industry technologies, structural shifts like Industry 4.0, ESG, M&amp;A intelligence and the macro risk to be aware of. This podcast is sponsored by Sterling Technology - the provider of premium virtual data room solutions for secure sharing of content and collaboration for industrials dealmaking. Hosted by Tom Lawrence and featuring David Bicknell, principal analyst at GlobalData covering the industrials sector.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Access Affordability – Insights Uncovered: A Real-World Data Podcast Series – Episode 4</title>
			<itunes:title>Access Affordability – Insights Uncovered: A Real-World Data Podcast Series – Episode 4</itunes:title>
			<pubDate>Fri, 14 Nov 2025 17:47:43 GMT</pubDate>
			<itunes:duration>21:13</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/69176b41e42e3466f23c435b/media.mp3" length="35668252" type="audio/mpeg"/>
			<guid isPermaLink="false">69176b41e42e3466f23c435b</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/69176b41e42e3466f23c435b</link>
			<acast:episodeId>69176b41e42e3466f23c435b</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOUS41Ut1ZXNOLqmTLDE1tRgujKQD+r9iIg1YseQP0g5Ui/zxqX4dyxpszM/1wOpLLxejjddyTEbCQ43z+wgIcH]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1763142443013-3c5a296a-4f01-4e51-8616-1e19de933641.jpeg"/>
			<description><![CDATA[<p>This is the fourth episode in our series, Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world data and its role in shaping healthcare decisions.</p><br><p>The episode will take a closer look at healthcare access in the United States – a topic that continues to dominate conversations in political, public health, and economic circles. While much of the national dialogue centers on insurance coverage and affordability, the reality is that access to care involves far more than simply having insurance.</p><br><p>Also covered in the episode are the policies, data, and real-world factors that influence healthcare access for the 92% of Americans who are insured.</p><br><p>Guests are:</p><br><p>- Liisa Palmer, Portfolio Leader for Real World Data Research &amp; Analytics at MarketScan</p><p>- And Katherine Shanahan, Senior Pharmacy Analytic Advisor for Health Insights, Truven’s healthcare analytics platform for payers and employers </p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This is the fourth episode in our series, Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world data and its role in shaping healthcare decisions.</p><br><p>The episode will take a closer look at healthcare access in the United States – a topic that continues to dominate conversations in political, public health, and economic circles. While much of the national dialogue centers on insurance coverage and affordability, the reality is that access to care involves far more than simply having insurance.</p><br><p>Also covered in the episode are the policies, data, and real-world factors that influence healthcare access for the 92% of Americans who are insured.</p><br><p>Guests are:</p><br><p>- Liisa Palmer, Portfolio Leader for Real World Data Research &amp; Analytics at MarketScan</p><p>- And Katherine Shanahan, Senior Pharmacy Analytic Advisor for Health Insights, Truven’s healthcare analytics platform for payers and employers </p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Charting the next chapter in obesity therapeutics</title>
			<itunes:title>Charting the next chapter in obesity therapeutics</itunes:title>
			<pubDate>Tue, 11 Nov 2025 13:03:50 GMT</pubDate>
			<itunes:duration>28:24</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/69133436830e2623bf63e8ed/media.mp3" length="40939855" type="audio/mpeg"/>
			<guid isPermaLink="false">69133436830e2623bf63e8ed</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/69133436830e2623bf63e8ed</link>
			<acast:episodeId>69133436830e2623bf63e8ed</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeN5ZDFA5WigNL2GVZHJI99J2zw0sTeqtewCO8pk9OX1Hrh8MDaJ7nK5sVOtvlGekHBBBkrurLXBsbAXxvf0kL+k]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1762866063158-f01fd8ae-205c-41c0-810f-6a463328201c.jpeg"/>
			<description><![CDATA[<p>Join us for the latest installment of Novotech’s expert podcast, exploring the rapidly evolving world of global obesity clinical trials and the transformative role of GLP-1 therapies.</p><br><p><em>Dr. Stecco is a healthcare executive with 25 years of leadership and medical monitoring experience across the pharmaceutical, biotech, and medical device sectors. A former Chief Medical Officer and consultant to over20 obesity-focused companies, she is also a practicing physician with deep expertise in treating obesity using therapies like GLP-1 receptor agonists, Orlistat, Qsymia, and Contrave. Dr.Stecco holds an MA and MD from the University of Southern California and completed her surgical training at Stanford University Medical Center.</em></p><p>&nbsp;</p><p><em>Gab is a seasoned clinical research professional with over 20 years of experience across both site and CRO settings. He has held key roles including Senior Study Coordinator, CRA, Project Manager, and Therapeutic Strategy Manager. Gab has significant expertise in Phase I–III clinical trials conducted in Australia and globally, with a strong focus on early-phase research — covering study design, protocol development, regulatory strategy, feasibility, budgeting, and timeline management. He currently leads the Strategy team for the obesity portfolio. Gab holds a Bachelor of Nursing and a Master of Health Sciences in Health Administration.​</em></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Join us for the latest installment of Novotech’s expert podcast, exploring the rapidly evolving world of global obesity clinical trials and the transformative role of GLP-1 therapies.</p><br><p><em>Dr. Stecco is a healthcare executive with 25 years of leadership and medical monitoring experience across the pharmaceutical, biotech, and medical device sectors. A former Chief Medical Officer and consultant to over20 obesity-focused companies, she is also a practicing physician with deep expertise in treating obesity using therapies like GLP-1 receptor agonists, Orlistat, Qsymia, and Contrave. Dr.Stecco holds an MA and MD from the University of Southern California and completed her surgical training at Stanford University Medical Center.</em></p><p>&nbsp;</p><p><em>Gab is a seasoned clinical research professional with over 20 years of experience across both site and CRO settings. He has held key roles including Senior Study Coordinator, CRA, Project Manager, and Therapeutic Strategy Manager. Gab has significant expertise in Phase I–III clinical trials conducted in Australia and globally, with a strong focus on early-phase research — covering study design, protocol development, regulatory strategy, feasibility, budgeting, and timeline management. He currently leads the Strategy team for the obesity portfolio. Gab holds a Bachelor of Nursing and a Master of Health Sciences in Health Administration.​</em></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>ESG and Critical Minerals: Do You Know Your Supply Chain?</title>
			<itunes:title>ESG and Critical Minerals: Do You Know Your Supply Chain?</itunes:title>
			<pubDate>Mon, 03 Nov 2025 15:30:07 GMT</pubDate>
			<itunes:duration>22:49</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/6908ca80471525d352a93e3c/media.mp3" length="38347146" type="audio/mpeg"/>
			<guid isPermaLink="false">6908ca80471525d352a93e3c</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/6908ca80471525d352a93e3c</link>
			<acast:episodeId>6908ca80471525d352a93e3c</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOUM9jQGClp0GkifpjdLt9zaDj+dZccTJL0AChkSl616NX6NgIJ6eh299ciPqNGEuhvanDrGEQRlfBaRtsXSR6E]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1762173722567-a86d6068-186b-491d-a6b2-5a1b1488f82f.jpeg"/>
			<description><![CDATA[<p>Supply chains for critical minerals are very complex, but several markets are making advances in traceability and provenance such as IRMA certification, ISO standards, EU Battery Passport. Queensland in Australia is taking learnings to inform its own traceability framework for critical minerals.</p><br><p>The second episode on critical minerals in Queensland gains insights into a supply chain report titled A Vision and Roadmap for Critical Minerals Provenance and Traceability, produced by FrontierSI in partnership with the Department of Natural Resources in Queensland. FrontierSI is a social enterprise that applies its expertise in location analytics to address environmental and industrial challenges. We learn more about the research, with guests:</p><br><p>- Gavin Kennedy, interim spatial sector lead at FrontierSI</p><p>- Jia-Urnn Lee, strategic growth lead at FrontierSI</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Supply chains for critical minerals are very complex, but several markets are making advances in traceability and provenance such as IRMA certification, ISO standards, EU Battery Passport. Queensland in Australia is taking learnings to inform its own traceability framework for critical minerals.</p><br><p>The second episode on critical minerals in Queensland gains insights into a supply chain report titled A Vision and Roadmap for Critical Minerals Provenance and Traceability, produced by FrontierSI in partnership with the Department of Natural Resources in Queensland. FrontierSI is a social enterprise that applies its expertise in location analytics to address environmental and industrial challenges. We learn more about the research, with guests:</p><br><p>- Gavin Kennedy, interim spatial sector lead at FrontierSI</p><p>- Jia-Urnn Lee, strategic growth lead at FrontierSI</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>A Deep Dive into Nitinol, The Smart Material – Advancing the Future of MedTech with Alleima – Ep5</title>
			<itunes:title>A Deep Dive into Nitinol, The Smart Material – Advancing the Future of MedTech with Alleima – Ep5</itunes:title>
			<pubDate>Mon, 03 Nov 2025 11:47:51 GMT</pubDate>
			<itunes:duration>9:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/69089668229e95a53f62fdb3/media.mp3" length="15272367" type="audio/mpeg"/>
			<guid isPermaLink="false">69089668229e95a53f62fdb3</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/69089668229e95a53f62fdb3</link>
			<acast:episodeId>69089668229e95a53f62fdb3</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOdHe2MP5pL4Q39WqWAPk2DCvaq1S3hZEIOHclu3864hoz6uf5qbAj7sBQH1nOXNgyTJfzDDb4ikmVz1g9hbJS/]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1762249749539-a6a918de-d078-42f8-8558-f2cf682422d6.jpeg"/>
			<description><![CDATA[<p>This episode explores the world of nitinol – a material that’s revolutionising medical device design. The episode learns more about the super-elasticity properties of nitinol, which can undergo significant deformation and still return to its original shape. These properties make nitinol an optimum material for stents and guidewires in cardiovascular care. Also discussed are how nitinol fits into the trend of smaller and smarter medical devices.</p><br><p>Guests of the fifth episode of the Advancing the Future of MedTech with Alleima podcast series are:</p><br><p>- Bernd Vogel, global technology and innovation manager at Alleima’s Medical unit</p><p>- Steffen Müller, sales and marketing director at Alleima’s Medical unit</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This episode explores the world of nitinol – a material that’s revolutionising medical device design. The episode learns more about the super-elasticity properties of nitinol, which can undergo significant deformation and still return to its original shape. These properties make nitinol an optimum material for stents and guidewires in cardiovascular care. Also discussed are how nitinol fits into the trend of smaller and smarter medical devices.</p><br><p>Guests of the fifth episode of the Advancing the Future of MedTech with Alleima podcast series are:</p><br><p>- Bernd Vogel, global technology and innovation manager at Alleima’s Medical unit</p><p>- Steffen Müller, sales and marketing director at Alleima’s Medical unit</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[How Power Plant Owners can Unlock New Revenue Streams & Capacity]]></title>
			<itunes:title><![CDATA[How Power Plant Owners can Unlock New Revenue Streams & Capacity]]></itunes:title>
			<pubDate>Fri, 24 Oct 2025 09:11:25 GMT</pubDate>
			<itunes:duration>18:29</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68fb42bd18bcdad2abfac9cb/media.mp3" length="26645946" type="audio/mpeg"/>
			<guid isPermaLink="false">68fb42bd18bcdad2abfac9cb</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68fb42bd18bcdad2abfac9cb</link>
			<acast:episodeId>68fb42bd18bcdad2abfac9cb</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeNB/W5k4cJTFwYZCmjkvpAmCMEeQ3q4wwruQAuTUwcZODKJdHXvkqtumUvN2Gfwzz6twW+1vjIXurhq2DXXSLHJ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1761297058945-353f4e06-57e9-435a-a93e-bb4e05d65142.jpeg"/>
			<description><![CDATA[This episode focuses on how operators can expand revenue by staking their claim in the energy transition, enhancing grid stability as electricity demand grows and conventional plants retire. It looks at the potential of ancillary services, synchronous condensers, and hybrid Rotating Grid Stabilizer conversions, with the Townsville Power Station in Australia features as a case study. With turbine upgrades boosting both output and efficiency, illustrated by results from California’s High Desert Power Plant, the discussion reflects how Siemens Energy are helping power plants play a critical role in a renewable-forward future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[This episode focuses on how operators can expand revenue by staking their claim in the energy transition, enhancing grid stability as electricity demand grows and conventional plants retire. It looks at the potential of ancillary services, synchronous condensers, and hybrid Rotating Grid Stabilizer conversions, with the Townsville Power Station in Australia features as a case study. With turbine upgrades boosting both output and efficiency, illustrated by results from California’s High Desert Power Plant, the discussion reflects how Siemens Energy are helping power plants play a critical role in a renewable-forward future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>The Critical Minerals Rush: The Role of Queensland</title>
			<itunes:title>The Critical Minerals Rush: The Role of Queensland</itunes:title>
			<pubDate>Fri, 24 Oct 2025 07:41:54 GMT</pubDate>
			<itunes:duration>26:15</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68fb2dc28e51ce908996cc09/media.mp3" length="44123567" type="audio/mpeg"/>
			<guid isPermaLink="false">68fb2dc28e51ce908996cc09</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68fb2dc28e51ce908996cc09</link>
			<acast:episodeId>68fb2dc28e51ce908996cc09</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOnayccX/l153RpSDDZ6WMPoXo6vBpQLETJniwK6o16mPiDqGig9kmtXwjOz87IBi+YwNeQbm+8iahxQOWrQbm3]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1761291703220-b160ff04-d012-4cc7-b69b-a1ba218152d3.jpeg"/>
			<description><![CDATA[<p>Critical minerals are essential for future technologies such as electric vehicles, semiconductors, and renewable energy installations. Australia, and especially Queensland, has abundant critical mineral deposits to meet this demand.</p><br><p>In this episode, we explore what Queensland has to offer in this vital industry. The first guest is Namali Mackay, managing director of Critical Minerals Association Australia.</p><p>The level of progress in critical minerals in Queensland would not be possible without the support of the state government. </p><br><p>The second guest is Paul Holden, the lead of Critical Minerals Queensland, a newly created office by the Queensland Government focused on advancing the potential of the state’s critical minerals sector.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Critical minerals are essential for future technologies such as electric vehicles, semiconductors, and renewable energy installations. Australia, and especially Queensland, has abundant critical mineral deposits to meet this demand.</p><br><p>In this episode, we explore what Queensland has to offer in this vital industry. The first guest is Namali Mackay, managing director of Critical Minerals Association Australia.</p><p>The level of progress in critical minerals in Queensland would not be possible without the support of the state government. </p><br><p>The second guest is Paul Holden, the lead of Critical Minerals Queensland, a newly created office by the Queensland Government focused on advancing the potential of the state’s critical minerals sector.</p><p><br></p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[Flexibility & Profitability in the Age of Renewables: What Plant Owners Need to Know]]></title>
			<itunes:title><![CDATA[Flexibility & Profitability in the Age of Renewables: What Plant Owners Need to Know]]></itunes:title>
			<pubDate>Wed, 01 Oct 2025 13:17:31 GMT</pubDate>
			<itunes:duration>14:18</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68dd29eb46a2532cddc83a41/media.mp3" length="20621502" type="audio/mpeg"/>
			<guid isPermaLink="false">68dd29eb46a2532cddc83a41</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68dd29eb46a2532cddc83a41</link>
			<acast:episodeId>68dd29eb46a2532cddc83a41</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeN678Ys6ibN504w0XndwjaVOsqWJkASLC3QO1pz6C8UzCzdJzB4+zTHvDWO9JTSTphveM+dRqSdVUdmQXuXEDIv]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1759324612035-ac01c3ec-05cc-4c8d-ac5f-88771a7525bc.jpeg"/>
			<description><![CDATA[Across some of the world’s major energy markets, rising shares of wind and solar are reshaping dispatch profiles and creating new operational challenges. How should plant owners respond? This podcast explores how a rising share of renewables in the energy mix is reshaping power plant operations and profitability. It examines the capabilities operators now need - such as faster start-ups, high ramp rates, and part-load efficiency - and how Siemens Energy’s Flex-Power Services can deliver them.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[Across some of the world’s major energy markets, rising shares of wind and solar are reshaping dispatch profiles and creating new operational challenges. How should plant owners respond? This podcast explores how a rising share of renewables in the energy mix is reshaping power plant operations and profitability. It examines the capabilities operators now need - such as faster start-ups, high ramp rates, and part-load efficiency - and how Siemens Energy’s Flex-Power Services can deliver them.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Reflecting on 2025 Trend Predictions – The Zelta Podcast – Episode 5</title>
			<itunes:title>Reflecting on 2025 Trend Predictions – The Zelta Podcast – Episode 5</itunes:title>
			<pubDate>Fri, 19 Sep 2025 08:54:52 GMT</pubDate>
			<itunes:duration>29:31</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68cd1a5d88c516d26efaeaba/media.mp3" length="49604892" type="audio/mpeg"/>
			<guid isPermaLink="false">68cd1a5d88c516d26efaeaba</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68cd1a5d88c516d26efaeaba</link>
			<acast:episodeId>68cd1a5d88c516d26efaeaba</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMbq+miS32nIlNBpg5FgKR8qwa/ITTSnKrX23nodg7zHRWxnLvCwrIQBUUfcrJ2QtxJ9v1CYEMw6quPbWeI0G1+]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1758269712308-76793850-498f-4b6d-a8f1-3b0ba1eecbc6.jpeg"/>
			<description><![CDATA[<p>This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and ClinicalTrialsArena.com, titled ‘Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses’. </p><br><p>The article examined the financial challenges facing clinical trials, which have created a more risk-averse landscape. It explored the digital solutions that could be key for sponsors and CROs to optimize budgets and resources, as well as the trends to watch out for in 2025.</p><br><p>The interviewee for that article was Jennifer Duff, Executive Vice President and General Manager of Zelta by Merative Clinical Trials Solutions. Jennifer is the guest for this episode, where we revisit the original predictions to see how accurate they were and if there were any surprises.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and ClinicalTrialsArena.com, titled ‘Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses’. </p><br><p>The article examined the financial challenges facing clinical trials, which have created a more risk-averse landscape. It explored the digital solutions that could be key for sponsors and CROs to optimize budgets and resources, as well as the trends to watch out for in 2025.</p><br><p>The interviewee for that article was Jennifer Duff, Executive Vice President and General Manager of Zelta by Merative Clinical Trials Solutions. Jennifer is the guest for this episode, where we revisit the original predictions to see how accurate they were and if there were any surprises.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Insights Uncovered: A Real-World Data Podcast Series – How RWD Furthers Understanding of Pregnancy  – Ep3</title>
			<itunes:title>Insights Uncovered: A Real-World Data Podcast Series – How RWD Furthers Understanding of Pregnancy  – Ep3</itunes:title>
			<pubDate>Mon, 15 Sep 2025 09:11:07 GMT</pubDate>
			<itunes:duration>20:48</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68c7d82c666ba430d6a2cb06/media.mp3" length="34971018" type="audio/mpeg"/>
			<guid isPermaLink="false">68c7d82c666ba430d6a2cb06</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68c7d82c666ba430d6a2cb06</link>
			<acast:episodeId>68c7d82c666ba430d6a2cb06</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeNtzhfTTR7hIDbaDE+Ds3EZB839tqVsOElftoHOeJXKElJm8pTSD0UhHXOoYKDXm7MELSFfFbKmrE18+2ZVsKOU]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1757922565234-a0003553-277a-44aa-ab8c-135c046bfdac.jpeg"/>
			<description><![CDATA[<p>This podcast examines how real-world data (RWD) helps fill gaps in understanding maternal and infant health, particularly since pregnant individuals are often excluded from clinical trials.</p><br><p>The latest episode in the Insights Uncovered: Real-World Data Podcast Series speaks with experts at MarketScan to learn how RWD enables linking mother-infant records to aspects such as study outcomes, assessing medication safety, evaluating healthcare services, and monitoring pregnancy risk factors and public health policies<strong>.</strong></p><br><p>The guests from MarketScan are:</p><p><br></p><ul><li><strong>Elizabeth Packnett, MPH, Lead Researcher, Real World Data Research &amp; Analytics</strong></li><li><strong>Luke Boulanger, Director, Technology Product Management</strong></li><li><strong>Liisa Palmer, PhD, Portfolio Leader, Real World Data Research &amp; Analytics</strong></li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This podcast examines how real-world data (RWD) helps fill gaps in understanding maternal and infant health, particularly since pregnant individuals are often excluded from clinical trials.</p><br><p>The latest episode in the Insights Uncovered: Real-World Data Podcast Series speaks with experts at MarketScan to learn how RWD enables linking mother-infant records to aspects such as study outcomes, assessing medication safety, evaluating healthcare services, and monitoring pregnancy risk factors and public health policies<strong>.</strong></p><br><p>The guests from MarketScan are:</p><p><br></p><ul><li><strong>Elizabeth Packnett, MPH, Lead Researcher, Real World Data Research &amp; Analytics</strong></li><li><strong>Luke Boulanger, Director, Technology Product Management</strong></li><li><strong>Liisa Palmer, PhD, Portfolio Leader, Real World Data Research &amp; Analytics</strong></li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Thermocouples - Advancing the Future of MedTech with Alleima Medical - Ep4</title>
			<itunes:title>Thermocouples - Advancing the Future of MedTech with Alleima Medical - Ep4</itunes:title>
			<pubDate>Mon, 08 Sep 2025 11:01:50 GMT</pubDate>
			<itunes:duration>11:13</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68beb79fc7aaa3aeefb62890/media.mp3" length="16194241" type="audio/mpeg"/>
			<guid isPermaLink="false">68beb79fc7aaa3aeefb62890</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68beb79fc7aaa3aeefb62890</link>
			<acast:episodeId>68beb79fc7aaa3aeefb62890</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkePqwBNFbZydnHonz5SxSTz5Qs+clsazh+uKchKa2fDl6K3G+hbfZQQ7euCF499rUdJQ4Vz70qbT0BEcw0bW1MRX]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1757318571877-8ec73328-becb-4f25-81a1-9c127a2a53b3.jpeg"/>
			<description><![CDATA[<p>Episode four of the Advancing the Future of MedTech with Alleima series continues to cover the trend of smaller and smarter medical devices, with a focus on thermocouples.&nbsp;</p><br><p>Alleima Medical is a specialist provider of wire and wire-based solutions in advanced medical devices to sense, transmit, measure, or stimulate. The result is a life-changing difference to patients.</p><br><p>Guests for episode four are:</p><p><br></p><ul><li><strong>Kevin Benz, Strategic Marketing Manager at Alleima</strong></li><li><strong>Cacie McDorman, Global Product Manager for Wire Technologies</strong></li><li><strong>Jörg Karweg, Sales Area Manager&nbsp;EMEA / APAC</strong></li></ul><p><br></p><p>Learn more about the science behind thermocouples, a critical and transformative technology that is often overlooked.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Episode four of the Advancing the Future of MedTech with Alleima series continues to cover the trend of smaller and smarter medical devices, with a focus on thermocouples.&nbsp;</p><br><p>Alleima Medical is a specialist provider of wire and wire-based solutions in advanced medical devices to sense, transmit, measure, or stimulate. The result is a life-changing difference to patients.</p><br><p>Guests for episode four are:</p><p><br></p><ul><li><strong>Kevin Benz, Strategic Marketing Manager at Alleima</strong></li><li><strong>Cacie McDorman, Global Product Manager for Wire Technologies</strong></li><li><strong>Jörg Karweg, Sales Area Manager&nbsp;EMEA / APAC</strong></li></ul><p><br></p><p>Learn more about the science behind thermocouples, a critical and transformative technology that is often overlooked.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Our Experience is Your Strength – Climate-friendly packaging strategies: How can pharma drive sustainability? – Ep5</title>
			<itunes:title>Our Experience is Your Strength – Climate-friendly packaging strategies: How can pharma drive sustainability? – Ep5</itunes:title>
			<pubDate>Mon, 01 Sep 2025 10:50:43 GMT</pubDate>
			<itunes:duration>26:44</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68b57a83e9dcbdcab9089b14/media.mp3" length="38540437" type="audio/mpeg"/>
			<guid isPermaLink="false">68b57a83e9dcbdcab9089b14</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68b57a83e9dcbdcab9089b14</link>
			<acast:episodeId>68b57a83e9dcbdcab9089b14</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMbppsWhN+ipYQknyNxXkoNGZIhCJi+py/nrQ3O/WA6iJXbWDf/PzFtyC+lFf8EcAqoZ3PhgXSvQGwMfk3J0D8o]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1756723767603-6844ab6c-bfe6-49fc-b5e0-3b10ab4f6ef0.jpeg"/>
			<description><![CDATA[As sustainability becomes increasingly mission-critical, how can pharma take action? In this podcast, Sharp’s Hywel Woolf, Global Sustainability Manager, and Mitch Darnell, Structural Designer, join host Steve Jacobs to discuss how sustainability initiatives are evolving in the pharmaceutical sector and the role of innovative new packaging designs. As Woolf outlines the changing landscape, Darnell details the specific materials supporting a more sustainable future for pharma packaging. They both explain the role of Sharp’s Sustainable Materials Innovation Group in identifying and exploring these opportunities and also share a recent project that saw the implementation of a new carbon-reduced material for a key client on a commercial scale.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[As sustainability becomes increasingly mission-critical, how can pharma take action? In this podcast, Sharp’s Hywel Woolf, Global Sustainability Manager, and Mitch Darnell, Structural Designer, join host Steve Jacobs to discuss how sustainability initiatives are evolving in the pharmaceutical sector and the role of innovative new packaging designs. As Woolf outlines the changing landscape, Darnell details the specific materials supporting a more sustainable future for pharma packaging. They both explain the role of Sharp’s Sustainable Materials Innovation Group in identifying and exploring these opportunities and also share a recent project that saw the implementation of a new carbon-reduced material for a key client on a commercial scale.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Migration of Clinical Trial Data - The Zelta Podcast - Episode 4</title>
			<itunes:title>Migration of Clinical Trial Data - The Zelta Podcast - Episode 4</itunes:title>
			<pubDate>Thu, 28 Aug 2025 16:08:28 GMT</pubDate>
			<itunes:duration>41:16</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68b07efd46792aead138904e/media.mp3" length="69329034" type="audio/mpeg"/>
			<guid isPermaLink="false">68b07efd46792aead138904e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68b07efd46792aead138904e</link>
			<acast:episodeId>68b07efd46792aead138904e</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMPkzN3FbD3tuubDdm79SABBxW+N9JWTuziGbTSf3xi5iTxbMHAbhsFRATP2uQxL2rHM060uTvtnYRwFYyd7bdV]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1756397292706-89f66361-f053-4c6a-92dd-1c22eed5ad89.jpeg"/>
			<description><![CDATA[<p>Migrating clinical studies to a new platform required careful planning and is the focus of episode four in the Zelta Podcast series. We will be looking at the considerations for migrating clinical studies.&nbsp;</p><br><p>Also covered are the reasons for and against a migration, the next step once a migration has been agreed upon, who builds the study, and what success looks like.</p><br><p>Our guests are:</p><p><br></p><ul><li>Anjali Agrawal, Senior Life Sciences Consultant at Zelta by Merative</li><li>Isaac Erickson, Vice President of Consulting Services at Zelta by Merative</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Migrating clinical studies to a new platform required careful planning and is the focus of episode four in the Zelta Podcast series. We will be looking at the considerations for migrating clinical studies.&nbsp;</p><br><p>Also covered are the reasons for and against a migration, the next step once a migration has been agreed upon, who builds the study, and what success looks like.</p><br><p>Our guests are:</p><p><br></p><ul><li>Anjali Agrawal, Senior Life Sciences Consultant at Zelta by Merative</li><li>Isaac Erickson, Vice President of Consulting Services at Zelta by Merative</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[The Future of Consumer: Insights for Investors & Dealmakers]]></title>
			<itunes:title><![CDATA[The Future of Consumer: Insights for Investors & Dealmakers]]></itunes:title>
			<pubDate>Thu, 28 Aug 2025 11:14:42 GMT</pubDate>
			<itunes:duration>19:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68b03a2231d1369c3c74cb7c/media.mp3" length="28413729" type="audio/mpeg"/>
			<guid isPermaLink="false">68b03a2231d1369c3c74cb7c</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68b03a2231d1369c3c74cb7c</link>
			<acast:episodeId>68b03a2231d1369c3c74cb7c</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOYQf32fuZ5F3oefDrkRuVpJPHhYGI/xMKeIUD/GSUPttJmr1klYpuzqcpX2hpgltXKl+f6OX2oZ1AFintJ4W3s]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1756379543430-7ab2f7eb-ceda-4061-8881-f5b52fc251c7.jpeg"/>
			<description><![CDATA[This podcast, designed for consumer M&amp;A dealmakers and investors, highlights the most important themes driving major changes across the industry. The conversation covers technological innovation, evolving industry business models, ESG, the outlook for mergers and acquisitions, and the road ahead. It is sponsored by Sterling Technology—the provider of premium virtual data room solutions for secure sharing of content and collaboration for hospitality dealmaking.&nbsp;<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[This podcast, designed for consumer M&amp;A dealmakers and investors, highlights the most important themes driving major changes across the industry. The conversation covers technological innovation, evolving industry business models, ESG, the outlook for mergers and acquisitions, and the road ahead. It is sponsored by Sterling Technology—the provider of premium virtual data room solutions for secure sharing of content and collaboration for hospitality dealmaking.&nbsp;<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[Our Experience is Your Strength – Managing your commercial drug launch – the good, the bad & the crazy!  – Ep4]]></title>
			<itunes:title><![CDATA[Our Experience is Your Strength – Managing your commercial drug launch – the good, the bad & the crazy!  – Ep4]]></itunes:title>
			<pubDate>Fri, 15 Aug 2025 07:46:05 GMT</pubDate>
			<itunes:duration>31:14</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/689ee5bd66f126ae3fe7e020/media.mp3" length="44994368" type="audio/mpeg"/>
			<guid isPermaLink="false">689ee5bd66f126ae3fe7e020</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/689ee5bd66f126ae3fe7e020</link>
			<acast:episodeId>689ee5bd66f126ae3fe7e020</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkePNiNBxH+2qiIB+E11seufNsTgcZRIj3sp2iu0miCUXlW6B4mL8sCDhIR4aXepcnEyA/AbaKPzJnPZq9MqQpf2L]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1755243908330-9b6c574e-8bc0-48bd-95e3-8133a13a86bc.jpeg"/>
			<description><![CDATA[This episode of <em>Our Experience is Your Strength </em>dives head-first<em> </em>into<em> </em>one of the most important phases in a drug’s lifecycle: the commercial launch. Steve Jacobs is joined by two seasoned experts from Sharp – Jeff Benedict, CCO, and Tonya Schmouder, Strategic Client Relationship Manager – to discuss the key steps to a smooth launch, especially when collaborating with CMOs. From missing links between clinical and commercial to timing considerations and those last-minute regulatory choke points that keep us up at night, this episode captures the good, the bad and the crazy of drug launches through real-life experiences, packed with useful advice for sponsors throughout.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[This episode of <em>Our Experience is Your Strength </em>dives head-first<em> </em>into<em> </em>one of the most important phases in a drug’s lifecycle: the commercial launch. Steve Jacobs is joined by two seasoned experts from Sharp – Jeff Benedict, CCO, and Tonya Schmouder, Strategic Client Relationship Manager – to discuss the key steps to a smooth launch, especially when collaborating with CMOs. From missing links between clinical and commercial to timing considerations and those last-minute regulatory choke points that keep us up at night, this episode captures the good, the bad and the crazy of drug launches through real-life experiences, packed with useful advice for sponsors throughout.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>ePRO - The Zelta Podcast - Ep3</title>
			<itunes:title>ePRO - The Zelta Podcast - Ep3</itunes:title>
			<pubDate>Thu, 07 Aug 2025 06:00:00 GMT</pubDate>
			<itunes:duration>24:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/689640517f93fda8b2562e4b/media.mp3" length="40582218" type="audio/mpeg"/>
			<guid isPermaLink="false">689640517f93fda8b2562e4b</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/689640517f93fda8b2562e4b</link>
			<acast:episodeId>689640517f93fda8b2562e4b</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeP9jp6AZplMsCj8A4KfRzI/8ezU8Ezl2IGUK+J5H8zg026Ca2F60+ioOCeWyexI5rvOTxOOvdAmPQ9DTVqshXVk]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1754671440104-2a63f8ab-e501-48c0-ab69-868e0570c4f5.jpeg"/>
			<description><![CDATA[<p>Episode three of The Zelta Podcast series looks at the current state of play for ePRO in the clinical trials industry.</p><br><p>The guest is Wes Fishburne, Principal Product Manager for Zelta by Merative. The discussion begins with hearing how trials approach ePRO, either as part of their clinical trials platform from the beginning or integrated from a 3rd-party provider.&nbsp;</p><br><p>The conversation also covers Zelta’s approach to ePRO and what led the company to embed it directly within the platform vs integration, before looking ahead to what the future may hold.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Episode three of The Zelta Podcast series looks at the current state of play for ePRO in the clinical trials industry.</p><br><p>The guest is Wes Fishburne, Principal Product Manager for Zelta by Merative. The discussion begins with hearing how trials approach ePRO, either as part of their clinical trials platform from the beginning or integrated from a 3rd-party provider.&nbsp;</p><br><p>The conversation also covers Zelta’s approach to ePRO and what led the company to embed it directly within the platform vs integration, before looking ahead to what the future may hold.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Key Market Trends for Medical Devices: A Different Perspective - Advancing the Future of MedTech with Alleima Medical - Ep3</title>
			<itunes:title>Key Market Trends for Medical Devices: A Different Perspective - Advancing the Future of MedTech with Alleima Medical - Ep3</itunes:title>
			<pubDate>Wed, 06 Aug 2025 07:27:09 GMT</pubDate>
			<itunes:duration>15:01</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/689303cfc952cf597889630f/media.mp3" length="25237098" type="audio/mpeg"/>
			<guid isPermaLink="false">689303cfc952cf597889630f</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/689303cfc952cf597889630f</link>
			<acast:episodeId>689303cfc952cf597889630f</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkePKnJQC+VrPyHA/6sIPVMlMXc6l4o32w0LCGpyJhf6udduk6akCjq5R3dnRCGNoda8FePO8N+p/g5fiWmf93+Of]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1754465161588-3886887e-be88-4edc-81c8-8edb8da88ee3.jpeg"/>
			<description><![CDATA[<p>A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of episode three of the Advancing the Future of MedTech with Alleima series. We build on the market trends covered in episode two and delve a little deeper with a different perspective. </p><br><p>Expert insight is provided by Alleima Medical, which designs, develops and manufactures many of the complex, specialist materials and solutions that are used to build advanced medical devices that are making a life-changing difference to patients. </p><br><p>Our guest is Kevin Benz, who is strategic marketing manager at Alleima Medical. He explains that his main focus is to understand the trends affecting the market, identify growth areas and opportunities for the company.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of episode three of the Advancing the Future of MedTech with Alleima series. We build on the market trends covered in episode two and delve a little deeper with a different perspective. </p><br><p>Expert insight is provided by Alleima Medical, which designs, develops and manufactures many of the complex, specialist materials and solutions that are used to build advanced medical devices that are making a life-changing difference to patients. </p><br><p>Our guest is Kevin Benz, who is strategic marketing manager at Alleima Medical. He explains that his main focus is to understand the trends affecting the market, identify growth areas and opportunities for the company.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Our Experience is Your Strength – Hurry up and wait! Avoiding delays and stock outs in your clinical supply – Ep3</title>
			<itunes:title>Our Experience is Your Strength – Hurry up and wait! Avoiding delays and stock outs in your clinical supply – Ep3</itunes:title>
			<pubDate>Mon, 04 Aug 2025 08:00:00 GMT</pubDate>
			<itunes:duration>27:46</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68761eea12713a20e1dece32/media.mp3" length="40032362" type="audio/mpeg"/>
			<guid isPermaLink="false">68761eea12713a20e1dece32</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68761eea12713a20e1dece32</link>
			<acast:episodeId>68761eea12713a20e1dece32</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeM9RDXcbPTcsze0qBOeN7Rri05H/2mwTcwPibHT/mAl5ElBsP3/5YT9GmvAz9eqlZrfLns8kueWBglwt83lAmv0]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752571591694-1143f1d0-cec6-4fac-bd03-c0f35fbe9cc0.jpeg"/>
			<description><![CDATA[<p>In this episode, clinical supply experts Melissa Peirsel and Sean McCaig explore the challenges of keeping clinical trials on schedule, without risking supply disruptions. With decades of experience across contract packaging and clinical services, Sharp brings insight into the common pitfalls of trial planning, from aggressive timelines to overestimated patient enrollment.</p><br><p>Peirsel and McCaig emphasize that success hinges on early planning and clear communication. Whether it’s understanding country-specific requirements, anticipating protocol amendments, or building in time for label translation, every detail matters. They discuss how Just-in-Time packaging, integrated IRT systems, and flexible supply models can help sponsors avoid stockouts while maintaining compliance.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this episode, clinical supply experts Melissa Peirsel and Sean McCaig explore the challenges of keeping clinical trials on schedule, without risking supply disruptions. With decades of experience across contract packaging and clinical services, Sharp brings insight into the common pitfalls of trial planning, from aggressive timelines to overestimated patient enrollment.</p><br><p>Peirsel and McCaig emphasize that success hinges on early planning and clear communication. Whether it’s understanding country-specific requirements, anticipating protocol amendments, or building in time for label translation, every detail matters. They discuss how Just-in-Time packaging, integrated IRT systems, and flexible supply models can help sponsors avoid stockouts while maintaining compliance.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Blockchain in Scotland: Cybersecurity - Ep4</title>
			<itunes:title>Blockchain in Scotland: Cybersecurity - Ep4</itunes:title>
			<pubDate>Mon, 28 Jul 2025 09:36:57 GMT</pubDate>
			<itunes:duration>23:43</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/688744ba6e658a8b3c471995/media.mp3" length="39859146" type="audio/mpeg"/>
			<guid isPermaLink="false">688744ba6e658a8b3c471995</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/688744ba6e658a8b3c471995</link>
			<acast:episodeId>688744ba6e658a8b3c471995</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeP04deSIi8sQflBmF0n3meh+eWQYReawdBCwetIMbyBqOj/HjxydDD+djoy/kmkmHTZJhFldCuMm8unRXHZh9pz]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1753693254175-07704270-9cc1-4436-a083-8ec459dc699a.jpeg"/>
			<description><![CDATA[<p>The fourth episode in the Blockchain in Scotland series covers cybersecurity, as we further explore the transformative potential of the technology across different industries.&nbsp;</p><br><p>The guest is Bill Buchanan, professor of cryptography at Edinburgh Napier University. He is also a member of Scotland's Blockchain &amp; Digital Trust Taskforce, and is a highly respected voice in blockchain and digital trust. The episode covers digital trust in online technologies and how it can be integrated into all activities online.&nbsp;</p><br><p>The discussion also spans the tools available in blockchain for secure data sharing, the possible transformations in official documents, and the support available for blockchain businesses in Scotland.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>The fourth episode in the Blockchain in Scotland series covers cybersecurity, as we further explore the transformative potential of the technology across different industries.&nbsp;</p><br><p>The guest is Bill Buchanan, professor of cryptography at Edinburgh Napier University. He is also a member of Scotland's Blockchain &amp; Digital Trust Taskforce, and is a highly respected voice in blockchain and digital trust. The episode covers digital trust in online technologies and how it can be integrated into all activities online.&nbsp;</p><br><p>The discussion also spans the tools available in blockchain for secure data sharing, the possible transformations in official documents, and the support available for blockchain businesses in Scotland.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Insights Uncovered: A Real-World Data Podcast Series – Why the healthcare industry needs linked data – Ep2</title>
			<itunes:title>Insights Uncovered: A Real-World Data Podcast Series – Why the healthcare industry needs linked data – Ep2</itunes:title>
			<pubDate>Thu, 24 Jul 2025 14:37:19 GMT</pubDate>
			<itunes:duration>17:13</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68824520a86e93496c8c4ad8/media.mp3" length="24814515" type="audio/mpeg"/>
			<guid isPermaLink="false">68824520a86e93496c8c4ad8</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68824520a86e93496c8c4ad8</link>
			<acast:episodeId>68824520a86e93496c8c4ad8</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOZPixCtd78AFQIj+p8SqrBGRlEDC8W4imY5XdgTm2eQifevCfKG3lDWG/E0LrN+uOEj3PKhxiKP5OMlEikmJr/]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1753367698394-756aefc1-1d14-4806-a370-3e50ffa90c20.jpeg"/>
			<description><![CDATA[<p>In this episode, we discuss how linked databases can help unlock the full potential of healthcare – gaining a complete patient view, having deeper insights, and utilizing precision in research. With an increasing amount of available data, healthcare researchers can get a comprehensive view into patient journeys, healthcare utilization, and costs. We’ll explore the importance of being able to take the next step with linked data – what do you do with it once you have it?</p><ul><li>Why getting your data sources to talk to each other can create new issues.</li><li>How linking data is becoming more critical in the real-world data/evidence space. What are some applications for its use?</li><li>“Frankensteining” data is not the answer. MarketScan leverages real-world evidence to help organizations uncover meaningful insights.</li></ul><p><br></p><p>With guests:</p><ul><li>Guenter Sauter PhD, Sr. Director, Technology Product Management at MarketScan</li><li>Liisa Palmer PhD, Portfolio Leader, Real World Data Research &amp; Analytics at MarketScan</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>In this episode, we discuss how linked databases can help unlock the full potential of healthcare – gaining a complete patient view, having deeper insights, and utilizing precision in research. With an increasing amount of available data, healthcare researchers can get a comprehensive view into patient journeys, healthcare utilization, and costs. We’ll explore the importance of being able to take the next step with linked data – what do you do with it once you have it?</p><ul><li>Why getting your data sources to talk to each other can create new issues.</li><li>How linking data is becoming more critical in the real-world data/evidence space. What are some applications for its use?</li><li>“Frankensteining” data is not the answer. MarketScan leverages real-world evidence to help organizations uncover meaningful insights.</li></ul><p><br></p><p>With guests:</p><ul><li>Guenter Sauter PhD, Sr. Director, Technology Product Management at MarketScan</li><li>Liisa Palmer PhD, Portfolio Leader, Real World Data Research &amp; Analytics at MarketScan</li></ul><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Offshore Wind in Scotland: Innovation - Ep3</title>
			<itunes:title>Offshore Wind in Scotland: Innovation - Ep3</itunes:title>
			<pubDate>Tue, 22 Jul 2025 09:29:38 GMT</pubDate>
			<itunes:duration>18:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/687f5a03fd9acfeba46ef999/media.mp3" length="30387978" type="audio/mpeg"/>
			<guid isPermaLink="false">687f5a03fd9acfeba46ef999</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/687f5a03fd9acfeba46ef999</link>
			<acast:episodeId>687f5a03fd9acfeba46ef999</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOer46wanfAp6UmZ6NLAGwNSTyPvp0PBoO2HRQa6ML4Hd6QBNPjX0OqNtIrvgjDlnVEaw6cDzKAIPjObBEEQuLP]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1753176566001-44d155dc-bb23-40e8-ab48-6a739deef35f.jpeg"/>
			<description><![CDATA[<p>This episode explores how innovations are helping to overcome some of the main obstacles to deliver a pipeline of Scottish offshore wind projects that could far exceed 40 gigawatts in generation capacity.</p><br><p>Our guest is Andy Macdonald, director of offshore wind development and operations at the ORE Catapult, as well as chair of the Scottish Offshore Wind Energy Council's Innovation Working Group.&nbsp;</p><br><p>The conversation covers the strengths Scotland has in offshore wind innovations, the support available for offshore wind innovators, as well as examples of project scale-ups.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>This episode explores how innovations are helping to overcome some of the main obstacles to deliver a pipeline of Scottish offshore wind projects that could far exceed 40 gigawatts in generation capacity.</p><br><p>Our guest is Andy Macdonald, director of offshore wind development and operations at the ORE Catapult, as well as chair of the Scottish Offshore Wind Energy Council's Innovation Working Group.&nbsp;</p><br><p>The conversation covers the strengths Scotland has in offshore wind innovations, the support available for offshore wind innovators, as well as examples of project scale-ups.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[Our Experience is Your Strength – High value, low loss: Developing a successful GT fill&finish strategy – Ep2]]></title>
			<itunes:title><![CDATA[Our Experience is Your Strength – High value, low loss: Developing a successful GT fill&finish strategy – Ep2]]></itunes:title>
			<pubDate>Mon, 21 Jul 2025 08:00:00 GMT</pubDate>
			<itunes:duration>23:50</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/687616d701becb6b317f9319/media.mp3" length="34387736" type="audio/mpeg"/>
			<guid isPermaLink="false">687616d701becb6b317f9319</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/687616d701becb6b317f9319</link>
			<acast:episodeId>687616d701becb6b317f9319</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMrjD/uhOvASgDq7Jx/Pmd9gpMMa++plUc2lWmV1ECnVJoSL79T4684PeGdRrmlj56zcq+Cb1UN1RoMI+CWCQa8]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752569510368-ac9c0241-2e05-4bfe-9570-0f9449b813dc.jpeg"/>
			<description><![CDATA[In this episode of <em>Our Experience is Your Strength</em>, host Steve Jacobs speaks with Xufeng Sun, Vice President of Manufacturing Science &amp; Technology at Sharp Sterile, about the critical, and often underestimated, challenges of gene therapy fill &amp; finish. With limited drug substance, high manufacturing costs, and tight quality constraints, every drop counts. Sun offers deep insight into the technical, logistical, and strategic considerations required to ensure success.&nbsp;The conversation covers key planning stages, from understanding clinical demand and testing requirements to visualising the entire manufacturing process, including thawing, filtration, and final inspection steps.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[In this episode of <em>Our Experience is Your Strength</em>, host Steve Jacobs speaks with Xufeng Sun, Vice President of Manufacturing Science &amp; Technology at Sharp Sterile, about the critical, and often underestimated, challenges of gene therapy fill &amp; finish. With limited drug substance, high manufacturing costs, and tight quality constraints, every drop counts. Sun offers deep insight into the technical, logistical, and strategic considerations required to ensure success.&nbsp;The conversation covers key planning stages, from understanding clinical demand and testing requirements to visualising the entire manufacturing process, including thawing, filtration, and final inspection steps.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Key Market Trends for Medical Devices - Advancing the Future of MedTech with Alleima - Ep2</title>
			<itunes:title>Key Market Trends for Medical Devices - Advancing the Future of MedTech with Alleima - Ep2</itunes:title>
			<pubDate>Mon, 14 Jul 2025 14:56:02 GMT</pubDate>
			<itunes:duration>21:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/68751a8412713a20e1982be6/media.mp3" length="36456810" type="audio/mpeg"/>
			<guid isPermaLink="false">68751a8412713a20e1982be6</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/68751a8412713a20e1982be6</link>
			<acast:episodeId>68751a8412713a20e1982be6</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkePOGjVWqGyRhV0pCCNcyYEAf5CyWBb5LqQ1gHdWdZmb5Gwj70EIkVFrXyvtvhuIZqk5Lanfo5jOupS6GWQ7XVFT]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752504913099-5a45fe24-098c-4502-bb7b-4a03c3f8c05f.jpeg"/>
			<description><![CDATA[<p>The medical device industry is changing. Devices are getting smarter and smaller, which requires specific materials to meet growing demands. In this second episode of the Alleima&nbsp;podcast&nbsp;series, we explore the&nbsp;market&nbsp;trends, future projections, and the effect this will have on specific types of materials such as nitinol and specialist medical wire.&nbsp;</p><br><p>The guest is Charlie Whelan, senior director of consulting at GlobalData’s Medical Technology group.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>The medical device industry is changing. Devices are getting smarter and smaller, which requires specific materials to meet growing demands. In this second episode of the Alleima&nbsp;podcast&nbsp;series, we explore the&nbsp;market&nbsp;trends, future projections, and the effect this will have on specific types of materials such as nitinol and specialist medical wire.&nbsp;</p><br><p>The guest is Charlie Whelan, senior director of consulting at GlobalData’s Medical Technology group.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Our Experience is Your Strength – Formulation: Moving from molecule to clinic – Ep1</title>
			<itunes:title>Our Experience is Your Strength – Formulation: Moving from molecule to clinic – Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:39:32 GMT</pubDate>
			<itunes:duration>24:44</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8d34fe25e4b1db58a70b/media.mp3" length="35647585" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8d34fe25e4b1db58a70b</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8d34fe25e4b1db58a70b</link>
			<acast:episodeId>686e8d34fe25e4b1db58a70b</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOMa9k4dlc3OeYrMSL6gtQhW5xU4MJCIv5DTsxfLUrvsJYCmocYwhznYLFSN1IGzAd/BR+4Sn+AI2CrGcNWJruZ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752075555861-faa21a8b-abb8-40a8-a38a-c46ee55c4742.jpeg"/>
			<description><![CDATA[In this debut episode of the <em>Our Experience is Your Strength</em> podcast series, host Steve Jacobs sits down with Devin Corson, Senior Formulation Scientist at Sharp Clinical, to explore the journey of drug formulation. Devin shares her unique perspective on the challenges and rewards of moving a molecule from the lab bench to first-in-human trials, drawing on her background in both quality and formulation development. She highlights the critical considerations in scale-up and stresses the importance of early and thorough stability testing. She addresses formulation-specific obstacles and the need to tailor dosage forms to specific patient populations. The conversation also touches on real-world issues, from ingredient sourcing difficulties still lingering post-COVID to regulatory differences between regions. Through it all, Devin’s message is clear: mission drives motivation, and patient-first thinking is key to successful formulation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[In this debut episode of the <em>Our Experience is Your Strength</em> podcast series, host Steve Jacobs sits down with Devin Corson, Senior Formulation Scientist at Sharp Clinical, to explore the journey of drug formulation. Devin shares her unique perspective on the challenges and rewards of moving a molecule from the lab bench to first-in-human trials, drawing on her background in both quality and formulation development. She highlights the critical considerations in scale-up and stresses the importance of early and thorough stability testing. She addresses formulation-specific obstacles and the need to tailor dosage forms to specific patient populations. The conversation also touches on real-world issues, from ingredient sourcing difficulties still lingering post-COVID to regulatory differences between regions. Through it all, Devin’s message is clear: mission drives motivation, and patient-first thinking is key to successful formulation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[The Vertical Advantage: Exploring Alleima's Innovation Strategy – Ep1]]></title>
			<itunes:title><![CDATA[The Vertical Advantage: Exploring Alleima's Innovation Strategy – Ep1]]></itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:37:32 GMT</pubDate>
			<itunes:duration>30:32</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8cbcfe0897380e2b0879/media.mp3" length="43986779" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8cbcfe0897380e2b0879</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8cbcfe0897380e2b0879</link>
			<acast:episodeId>686e8cbcfe0897380e2b0879</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOwg9TCCUSPnhF7QrkgmQiy59PSAwkC7z6A4qGMe/MDgBGopCTeamji+6JyBUeTMxzxjz+yJcpWgCD5fyFUK5Re]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752075431844-ff38ff75-2ab8-4977-8990-148a06402c9a.jpeg"/>
			<description><![CDATA[<p>Alleima’s medical unit is a progressive, vertically integrated partner of global OEMs, dedicated to designing, developing, and manufacturing life-changing medical solutions. The company's fully integrated value chain, from R&amp;D to commercialisation, ensures industry-leading technology, quality, sustainability, and circularity. Today, 80% of our finished products are made from recycled materials, with a goal of 83% by 2030.</p><br><p>Meet our guest:&nbsp;Gary&nbsp;Davies</p><br><p>With over 30 years of experience in specialty materials,&nbsp;Gary&nbsp;Davies is a recognised leader in the industry. He began his journey at Sandvik more than two decades ago — an organisation that spun off Alleima in 2022 — which has since played a pivotal role in advancing materials innovation for medical applications.</p><br><p>Gary&nbsp;holds master’s degrees in Chemical Engineering, Materials Science and Engineering, and Business Administration. For nearly a decade, he served as President of Alleima’s medical business unit, and has recently stepped into the role of Vice President of Strategic Business Development – Medical, where he focuses on long-term growth and innovation in one of Alleima’s core strategic areas.</p><br><p>In 2021, Gary was part of the team honored with the prestigious Wilhelm Haglund Medal for “Product Developer of the Year” within the Sandvik Group. This award recognised their significant contribution with the medical wire program—an achievement that stood out across Sandvik’s global portfolio for its impact on product development and innovation.</p><br><p>Join us as&nbsp;Gary&nbsp;shares insights from his career at the intersection of advanced materials and medical technology — and what’s next for the future of medical device development.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Alleima’s medical unit is a progressive, vertically integrated partner of global OEMs, dedicated to designing, developing, and manufacturing life-changing medical solutions. The company's fully integrated value chain, from R&amp;D to commercialisation, ensures industry-leading technology, quality, sustainability, and circularity. Today, 80% of our finished products are made from recycled materials, with a goal of 83% by 2030.</p><br><p>Meet our guest:&nbsp;Gary&nbsp;Davies</p><br><p>With over 30 years of experience in specialty materials,&nbsp;Gary&nbsp;Davies is a recognised leader in the industry. He began his journey at Sandvik more than two decades ago — an organisation that spun off Alleima in 2022 — which has since played a pivotal role in advancing materials innovation for medical applications.</p><br><p>Gary&nbsp;holds master’s degrees in Chemical Engineering, Materials Science and Engineering, and Business Administration. For nearly a decade, he served as President of Alleima’s medical business unit, and has recently stepped into the role of Vice President of Strategic Business Development – Medical, where he focuses on long-term growth and innovation in one of Alleima’s core strategic areas.</p><br><p>In 2021, Gary was part of the team honored with the prestigious Wilhelm Haglund Medal for “Product Developer of the Year” within the Sandvik Group. This award recognised their significant contribution with the medical wire program—an achievement that stood out across Sandvik’s global portfolio for its impact on product development and innovation.</p><br><p>Join us as&nbsp;Gary&nbsp;shares insights from his career at the intersection of advanced materials and medical technology — and what’s next for the future of medical device development.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Offshore Wind in Scotland: Building the Supply Chain - Ep2</title>
			<itunes:title>Offshore Wind in Scotland: Building the Supply Chain - Ep2</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:36:43 GMT</pubDate>
			<itunes:duration>32:38</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8c8bea74e132fb2d890f/media.mp3" length="62666691" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8c8bea74e132fb2d890f</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8c8bea74e132fb2d890f</link>
			<acast:episodeId>686e8c8bea74e132fb2d890f</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOPxoz3SR6hcJ8Om7Q51Sln11GooIo8dWOxpz8Tf9EhzuYlk/EoiF9zNOQ5u6e/eAY+N9DBicxYe7w6OF4EyZrf]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752075397638-0cb024a5-fb1d-44b0-a0c6-c52c62418eb6.jpeg"/>
			<description><![CDATA[<p>Offshore wind is integral to Scotland’s plans to reach net zero by 2045. This series looks at how Scotland is delivering on its ambition in offshore wind.</p><br><p>With around 45GW of generation capacity in the works and the ScotWind and INTOG leasing rounds driving growth, we explore the different aspects required to develop this new vital clean energy industry.</p><br><p>In this episode, we focus on how the supply chain is developing to meet the sheer scale of demand – in new areas such as floating wind.</p><br><p>Our guest is Anil Sayhan, who is programme director of the Offshore Wind Growth Partnership, which has supported around 350 offshore wind projects and aims to accelerate development of the UK’s offshore wind supply chain. Anil is responsible for delivery of all OWGP programmes.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Offshore wind is integral to Scotland’s plans to reach net zero by 2045. This series looks at how Scotland is delivering on its ambition in offshore wind.</p><br><p>With around 45GW of generation capacity in the works and the ScotWind and INTOG leasing rounds driving growth, we explore the different aspects required to develop this new vital clean energy industry.</p><br><p>In this episode, we focus on how the supply chain is developing to meet the sheer scale of demand – in new areas such as floating wind.</p><br><p>Our guest is Anil Sayhan, who is programme director of the Offshore Wind Growth Partnership, which has supported around 350 offshore wind projects and aims to accelerate development of the UK’s offshore wind supply chain. Anil is responsible for delivery of all OWGP programmes.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Offshore Wind in Scotland: The Focus on Ports - Ep1</title>
			<itunes:title>Offshore Wind in Scotland: The Focus on Ports - Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:34:22 GMT</pubDate>
			<itunes:duration>29:19</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8bfffe0897380e2acdf8/media.mp3" length="56314563" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8bfffe0897380e2acdf8</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://www.power-technology.com/sector/partners/green-energy-transition</link>
			<acast:episodeId>686e8bfffe0897380e2acdf8</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOT54GC9+n3Pa4c6uwjTqtKqZyYI/yG7gKVr/6TXhtv4gvIeoA8kRARfXl2m7Inj3MOwtdjlFYTfRFM9imKllQk]]></acast:settings>
			<itunes:subtitle>The Transformation Underway</itunes:subtitle>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752075141853-482f8ffe-6c5b-4021-95cd-240e211e90b3.jpeg"/>
			<description><![CDATA[<p>Ports are vital for delivering Scotland's ambitions in offshore wind. All Scottish ports, big and small, can play important roles.</p><br><p>Many historic ports in Scotland are adapting and upgrading to meet the demands of the offshore wind industry. The larger ports are starting the shift from oil and gas to offshore wind, with some of the smaller facilities developing niches in certain services.</p><br><p>Our guests in this first episode are Stuart Wallace, CEO of Forth Ports Group, and Captain Tom Hutchison, CEO of Montrose Port Authority.</p><br><p>We discuss the opportunities available for offshore wind in Scotland, the challenges being overcome, and the progress being made.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Ports are vital for delivering Scotland's ambitions in offshore wind. All Scottish ports, big and small, can play important roles.</p><br><p>Many historic ports in Scotland are adapting and upgrading to meet the demands of the offshore wind industry. The larger ports are starting the shift from oil and gas to offshore wind, with some of the smaller facilities developing niches in certain services.</p><br><p>Our guests in this first episode are Stuart Wallace, CEO of Forth Ports Group, and Captain Tom Hutchison, CEO of Montrose Port Authority.</p><br><p>We discuss the opportunities available for offshore wind in Scotland, the challenges being overcome, and the progress being made.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Blockchain in Scotland: The Benefits for Healthcare - Ep3</title>
			<itunes:title>Blockchain in Scotland: The Benefits for Healthcare - Ep3</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:31:08 GMT</pubDate>
			<itunes:duration>20:49</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8b3dea74e132fb2cc87f/media.mp3" length="34977784" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8b3dea74e132fb2cc87f</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8b3dea74e132fb2cc87f</link>
			<acast:episodeId>686e8b3dea74e132fb2cc87f</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeN3oIjDz4lLJx4R5NVsRayaWAMFomfE0Jl3OrKXwk5XAIBgxLnxgiCDXPVwH8nybQw9JHlIypGGhZzNr740gcbG]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752075024773-267e3f84-0902-485e-ba57-572179c15cf4.jpeg"/>
			<description><![CDATA[<p>Blockchain offers many potential benefits for healthcare, which is the focus of the third episode in the Blockchain in Scotland series.</p><br><p>The guest is Chaloner Chute, Chief Technology Officer at Scotland's Digital Health &amp; Care Innovation Centre.&nbsp;Chaloner has been involved with several projects in healthcare that harness distributed ledgers and other trust technologies.&nbsp;</p><br><p>Scotland has a rich history of health innovations. Blockchain could join them as the understanding grows around the advantages.&nbsp;This episode also explores some of the obstacle to overcome to fully unlock the strengths of blockchain for patients and health services alike.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Blockchain offers many potential benefits for healthcare, which is the focus of the third episode in the Blockchain in Scotland series.</p><br><p>The guest is Chaloner Chute, Chief Technology Officer at Scotland's Digital Health &amp; Care Innovation Centre.&nbsp;Chaloner has been involved with several projects in healthcare that harness distributed ledgers and other trust technologies.&nbsp;</p><br><p>Scotland has a rich history of health innovations. Blockchain could join them as the understanding grows around the advantages.&nbsp;This episode also explores some of the obstacle to overcome to fully unlock the strengths of blockchain for patients and health services alike.</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Blockchain in Scotland: Evolving Uses in Financial Services – Ep2</title>
			<itunes:title>Blockchain in Scotland: Evolving Uses in Financial Services – Ep2</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:28:09 GMT</pubDate>
			<itunes:duration>18:35</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8a898d3d6839f40b6de2/media.mp3" length="35690691" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8a898d3d6839f40b6de2</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8a898d3d6839f40b6de2</link>
			<acast:episodeId>686e8a898d3d6839f40b6de2</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeO820TFpU4BCFIASS3kh3nWOXtgGilpMFCcoajbMZhaBmOnwnH8aTP5LYSQw4l0lMER3ws/KDJ5iteihMNUgsE8]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074794827-cb6f740f-00d6-4afa-afdf-2bb71e39dfd7.jpeg"/>
			<description><![CDATA[<p> Episode 2 of our Blockchain in Scotland series looks at the evolving uses of the technology in financial services, from original uses in crypto to more mainstream applications. </p><p> </p><p>Our guest is James Ball, who leads product development at Nethermind for strategic projects and institutional offerings. Nethermind is a blockchain research and engineering company. The company was founded in 2017, and James led the opening of its Scottish office in 2024.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p> Episode 2 of our Blockchain in Scotland series looks at the evolving uses of the technology in financial services, from original uses in crypto to more mainstream applications. </p><p> </p><p>Our guest is James Ball, who leads product development at Nethermind for strategic projects and institutional offerings. Nethermind is a blockchain research and engineering company. The company was founded in 2017, and James led the opening of its Scottish office in 2024.&nbsp;</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Blockchain in Scotland: An Introduction to Building Trust – Ep1</title>
			<itunes:title>Blockchain in Scotland: An Introduction to Building Trust – Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:26:12 GMT</pubDate>
			<itunes:duration>33:10</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8a148d3d6839f40b487e/media.mp3" length="27887720" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8a148d3d6839f40b487e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8a148d3d6839f40b487e</link>
			<acast:episodeId>686e8a148d3d6839f40b487e</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMNe81u1RgAFdHSYcLnZfzr9+UwfTobzp1Z8tnHh9Fd8hgf/FM+GKNeNuoNF1gsZGN1k0wpaMdKoUP99WZVcVbJ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074722371-f644fb01-ff26-4d79-b23d-fe5ad836c299.jpeg"/>
			<description><![CDATA[<p>Blockchain has the potential to transform data privacy and transparency in a diverse range of industries. For the technology to fulfil its immense promise, challenges around trust are being overcome in Scotland.</p><p>&nbsp;</p><p>This first episode of the Blockchain in Scotland series will look at the potential applications and economic benefits of the technology, while also addressing the misconceptions and exploring the multi-faceted national strategy to build trust.</p><p>&nbsp;</p><p>Our guests are:</p><p>- Peter Ferry, chair of Scotland’s Blockchain and Digital Trust Taskforce</p><p>- And Sarah Forbes, digital economy specialist at Scottish Enterprise</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[<p>Blockchain has the potential to transform data privacy and transparency in a diverse range of industries. For the technology to fulfil its immense promise, challenges around trust are being overcome in Scotland.</p><p>&nbsp;</p><p>This first episode of the Blockchain in Scotland series will look at the potential applications and economic benefits of the technology, while also addressing the misconceptions and exploring the multi-faceted national strategy to build trust.</p><p>&nbsp;</p><p>Our guests are:</p><p>- Peter Ferry, chair of Scotland’s Blockchain and Digital Trust Taskforce</p><p>- And Sarah Forbes, digital economy specialist at Scottish Enterprise</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Insights Uncovered: A Real-World Data Podcast Series – The importance of Social Determinants of Health (SDoH) – Ep1</title>
			<itunes:title>Insights Uncovered: A Real-World Data Podcast Series – The importance of Social Determinants of Health (SDoH) – Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:22:34 GMT</pubDate>
			<itunes:duration>17:42</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e893afe25e4b1db56f863/media.mp3" length="25535800" type="audio/mpeg"/>
			<guid isPermaLink="false">686e893afe25e4b1db56f863</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e893afe25e4b1db56f863</link>
			<acast:episodeId>686e893afe25e4b1db56f863</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeN7kXZDhYOnnTYT5WBhyNs0jIwoFD4Mmz2jK9xf76/rwUMnj3ybdiQkWE6zsPkjoXv+v1t4RJBbRIOo7HSEA+mz]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074533272-0a06c86d-2189-4566-80ec-ed73abd9845a.jpeg"/>
			<description><![CDATA[Drawing on the insight of real-world evidence experts MarketScan, this podcast takes a closer look at Social Determinants of Health (SDoH). Host Elsie Clark and guests Brenna Brady and Brian Davis unpack why they are important, how they have become central to patient care, and where research might go in the future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[Drawing on the insight of real-world evidence experts MarketScan, this podcast takes a closer look at Social Determinants of Health (SDoH). Host Elsie Clark and guests Brenna Brady and Brian Davis unpack why they are important, how they have become central to patient care, and where research might go in the future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>AI and Supervised Machine Learning in Clinical Trials – Ep2</title>
			<itunes:title>AI and Supervised Machine Learning in Clinical Trials – Ep2</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:21:01 GMT</pubDate>
			<itunes:duration>29:14</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e88de9af244138c8079ea/media.mp3" length="42136218" type="audio/mpeg"/>
			<guid isPermaLink="false">686e88de9af244138c8079ea</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e88de9af244138c8079ea</link>
			<acast:episodeId>686e88de9af244138c8079ea</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMG+KO1h7prDZVISFtGaPdag/ZoQ2ClA02GLqYALxbgyY3HGoxu1lk+Gor0aBBdHk44HnD8IZkhgHwhHNcETfIM]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074419378-445be28b-d443-4610-a928-15bfe4c43373.jpeg"/>
			<description><![CDATA[In episode two, we continue our conversation about AI and supervised machine learning in clinical trials with Walker Bradham, senior director of product management and design at Zelta by Merative. The discussion covers Zelta’s approach to AI, which is driven by use cases, the benefits of supervised ML for trials, and Zelta’s strategy and vision for AI.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[In episode two, we continue our conversation about AI and supervised machine learning in clinical trials with Walker Bradham, senior director of product management and design at Zelta by Merative. The discussion covers Zelta’s approach to AI, which is driven by use cases, the benefits of supervised ML for trials, and Zelta’s strategy and vision for AI.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>AI and Supervised Machine Learning in Clinical Trials – Ep1</title>
			<itunes:title>AI and Supervised Machine Learning in Clinical Trials – Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:20:00 GMT</pubDate>
			<itunes:duration>33:08</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e88a08d3d6839f40ae9f9/media.mp3" length="47756589" type="audio/mpeg"/>
			<guid isPermaLink="false">686e88a08d3d6839f40ae9f9</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e88a08d3d6839f40ae9f9</link>
			<acast:episodeId>686e88a08d3d6839f40ae9f9</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeNDLzIQVbBm25wsj3pWXxLECTFVHbfpYYK4202MOTj3Fd4TVUi1hiYfurCCx4btDr8MHaRpmmkX4L/sMkkXZchM]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074386534-b36aa30c-c5cc-4d22-85ff-d9f9956e415f.jpeg"/>
			<description><![CDATA[AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta will flesh out the use cases, with a focus on generative AI vs supervised machine learning models. The guest is Walker Bradham, senior director of product management and design at Zelta by Merative. He explains the exciting applications, but cautions about the possible pitfalls, and underlines why supervised ML has become the driver of Zelta’s AI approach.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta will flesh out the use cases, with a focus on generative AI vs supervised machine learning models. The guest is Walker Bradham, senior director of product management and design at Zelta by Merative. He explains the exciting applications, but cautions about the possible pitfalls, and underlines why supervised ML has become the driver of Zelta’s AI approach.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>The 2025 biotech landscape: perspectives and projections – Ep1</title>
			<itunes:title>The 2025 biotech landscape: perspectives and projections – Ep1</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:17:51 GMT</pubDate>
			<itunes:duration>21:09</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e88209af244138c803fc3/media.mp3" length="20755650" type="audio/mpeg"/>
			<guid isPermaLink="false">686e88209af244138c803fc3</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e88209af244138c803fc3</link>
			<acast:episodeId>686e88209af244138c803fc3</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkePY12couEHXaWbZ0owjElQuuZfqHxsCFX9c7Ldui4od7ith6lVP0NYEtRyd5nWjuw9dEeEp66uztEkpOA8O94fd]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074245143-0388e9e6-9330-4a6d-8f84-dba2b3fba75a.jpeg"/>
			<description><![CDATA[What lies ahead for the future of research, development and global pharmaceutical innovation? In the first of a new series of podcasts, we deep dive into the world of biotechnology with Aditya Kotta, Head of Business Development for North America and Europe, at Novotech.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[What lies ahead for the future of research, development and global pharmaceutical innovation? In the first of a new series of podcasts, we deep dive into the world of biotechnology with Aditya Kotta, Head of Business Development for North America and Europe, at Novotech.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[The Future of Hospitality, Travel & Tourism—Key Themes for 2025 and Beyond]]></title>
			<itunes:title><![CDATA[The Future of Hospitality, Travel & Tourism—Key Themes for 2025 and Beyond]]></itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:16:11 GMT</pubDate>
			<itunes:duration>16:06</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e87bbfe25e4b1db569dbf/media.mp3" length="23211473" type="audio/mpeg"/>
			<guid isPermaLink="false">686e87bbfe25e4b1db569dbf</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e87bbfe25e4b1db569dbf</link>
			<acast:episodeId>686e87bbfe25e4b1db569dbf</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeNAiiyfiaEe+esGSxaemteeff8ouN3Ci18g77AwTY546DDESHfHboiihQourzg56VEVP5GoJdUQBUpR02lRT7AQ]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752074160444-a2ad94ea-0c8e-422b-98a1-54aad69da7fe.jpeg"/>
			<description><![CDATA[The hospitality, travel &amp; tourism sectors are undergoing major changes. In this podcast, produced in association with Sterling Technology, Nick Wyatt discusses some of the key technology, industry, macro and M&amp;A themes shaping the future. From AI-driven personalization, cybersecurity concerns, low-cost evolution and premiumization to sustainability, geopolitics and M&amp;A activity, this wide-ranging and insightful conversation will inform investors and M&amp;A dealmakers seeking to navigate opportunities.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[The hospitality, travel &amp; tourism sectors are undergoing major changes. In this podcast, produced in association with Sterling Technology, Nick Wyatt discusses some of the key technology, industry, macro and M&amp;A themes shaping the future. From AI-driven personalization, cybersecurity concerns, low-cost evolution and premiumization to sustainability, geopolitics and M&amp;A activity, this wide-ranging and insightful conversation will inform investors and M&amp;A dealmakers seeking to navigate opportunities.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Episode #5: Digital Deals in Life Sciences – What Makes Them Different? – Deal Structure, Terms, and Series Conclusions</title>
			<itunes:title>Episode #5: Digital Deals in Life Sciences – What Makes Them Different? – Deal Structure, Terms, and Series Conclusions</itunes:title>
			<pubDate>Wed, 09 Jul 2025 15:00:03 GMT</pubDate>
			<itunes:duration>19:23</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e83f39af244138c7f139e/media.mp3" length="46380647" type="audio/mpeg"/>
			<guid isPermaLink="false">686e83f39af244138c7f139e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e83f39af244138c7f139e</link>
			<acast:episodeId>686e83f39af244138c7f139e</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMBrHuXazEAMZzecv2o1N832Jv6QeHRHDMKE4YZ4VTYYr8SakAQEIGprVC17kzWQe2oc9YjfQjVKVBq5Ix3y6IH]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752073197674-4e17a03d-b2d1-4c51-b145-abb6fd7510a2.jpeg"/>
			<description><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Episode #4: Digital Deals in Life Sciences – What Makes Them Different? – Due Diligence</title>
			<itunes:title>Episode #4: Digital Deals in Life Sciences – What Makes Them Different? – Due Diligence</itunes:title>
			<pubDate>Wed, 09 Jul 2025 14:59:07 GMT</pubDate>
			<itunes:duration>16:05</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e83bb9af244138c7f034e/media.mp3" length="38517393" type="audio/mpeg"/>
			<guid isPermaLink="false">686e83bb9af244138c7f034e</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e83bb9af244138c7f034e</link>
			<acast:episodeId>686e83bb9af244138c7f034e</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMwe0XIvxMgA9cY4vJJWO6C5YHx87GIfhx5xAinOTsVYZVd8ot0/G9zQPXJg3iXMqQRmbRj7VFJErIl1r7ZMAs+]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752073115683-810fd026-f171-4b42-b0e1-c5268bb28ddd.jpeg"/>
			<description><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title><![CDATA[Episode #3: Digital Deals in Life Sciences – What Makes Them Different? – Defining & Valuing the Asset]]></title>
			<itunes:title><![CDATA[Episode #3: Digital Deals in Life Sciences – What Makes Them Different? – Defining & Valuing the Asset]]></itunes:title>
			<pubDate>Wed, 09 Jul 2025 14:47:36 GMT</pubDate>
			<itunes:duration>18:41</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e8108fe25e4b1db548251/media.mp3" length="44725899" type="audio/mpeg"/>
			<guid isPermaLink="false">686e8108fe25e4b1db548251</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e8108fe25e4b1db548251</link>
			<acast:episodeId>686e8108fe25e4b1db548251</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeOArVhRKdsfQhvjtbMVIOcywdeVrc6gm17qhbwFjhcvaUwfvVuKT/x7+C+EXNfkwG6sac/F2wrfCihqbTyuewLE]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752072384376-64ecb3bc-6eb6-482c-bef6-c7de384acf31.jpeg"/>
			<description><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Episode #2: Digital Deals in Life Sciences – What Makes Them Different? – Information Governance</title>
			<itunes:title>Episode #2: Digital Deals in Life Sciences – What Makes Them Different? – Information Governance</itunes:title>
			<pubDate>Wed, 09 Jul 2025 14:44:26 GMT</pubDate>
			<itunes:duration>15:55</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e804a8d3d6839f407e40a/media.mp3" length="38103813" type="audio/mpeg"/>
			<guid isPermaLink="false">686e804a8d3d6839f407e40a</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e804a8d3d6839f407e40a</link>
			<acast:episodeId>686e804a8d3d6839f407e40a</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeMVe/cg6FsshrXKwDVV/r3foMU3Al289QDVadb2OQC76w9EPeA+a1FG+asmOZIisaF+ld5vAk4/Lqwbg3UeF539]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752072226432-a3dd7adf-b8fb-4446-8021-f7d4b9cf79bd.jpeg"/>
			<description><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
		<item>
			<title>Episode #1: Digital Deals in Life Sciences – What Makes Them Different? – Corporate Culture</title>
			<itunes:title>Episode #1: Digital Deals in Life Sciences – What Makes Them Different? – Corporate Culture</itunes:title>
			<pubDate>Wed, 09 Jul 2025 14:40:54 GMT</pubDate>
			<itunes:duration>14:01</itunes:duration>
			<enclosure url="https://sphinx.acast.com/p/open/s/686e5d928d3d6839f4faaadc/e/686e7f76fe0897380e2626e8/media.mp3" length="33574837" type="audio/mpeg"/>
			<guid isPermaLink="false">686e7f76fe0897380e2626e8</guid>
			<itunes:explicit>false</itunes:explicit>
			<link>https://shows.acast.com/the-b2b-podcast/episodes/686e7f76fe0897380e2626e8</link>
			<acast:episodeId>686e7f76fe0897380e2626e8</acast:episodeId>
			<acast:showId>686e5d928d3d6839f4faaadc</acast:showId>
			<acast:settings><![CDATA[FYjHyZbXWHZ7gmX8Pp1rmbKbhgrQiwYShz70Q9/ffXZMTtedvdcRQbP4eiLMjXzCKLPjEYLpGj+NMVKa+5C8pL4u/EOj1Vw4h5MMJYp0lCcFAe0fnxBJy/1ju4Qxy1fh8gO4DvlGA40yms2g0/hOkcrfHIopjTygHFqGwwOPKFIai4SuTvs86Lx3UYCyl6Zsek55MsZIdTeB+5/ZFWLfwwC7e0ga22MMDj2K+OqSkeNAroLzUMTjTqgmKcmSu9y1DoKf/wCw0ZhtYp2zoPGTLBD3lUf1TSD8jx5PdgTstbEe7XppKJrVOSKg/MP4U6VV]]></acast:settings>
			<itunes:episodeType>full</itunes:episodeType>
			<itunes:image href="https://assets.pippa.io/shows/686e5d928d3d6839f4faaadc/1752071954572-56e1c4db-986f-4388-b3eb-6fd690700dad.jpeg"/>
			<description><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></description>
			<itunes:summary><![CDATA[A podcast series with John Easton, board advisor at Sterling Technology - the provider of premium virtual data room solutions for life sciences dealmaking<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>]]></itunes:summary>
		</item>
    	<itunes:category text="Business"/>
    </channel>
</rss>
